Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells
Robbins P et al. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol 1997; 71: 9466.
In utero gene therapy: Transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses
Porada C et al. In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther 1998; 9: 1571.
Successful expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein
M Themis et al. Successful expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein. Gene Therapy 1999; 6: 1239-1248.
Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer
SK Schachtner, CA Buck, JM Bergelson, HS Baldwin. Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer. Gene Therapy 1999; 6: 1249-1257.
Report on the potential use of gene therapy in utero
Health Departments of the United Kingdom, November
Gene Therapy Advisory Committee. Report on the potential use of gene therapy in utero. Health Departments of the United Kingdom, November 1998. Hum Gene Ther 1999; 10: 689.